Cartesian Growth Corp II Files 8-K Report

TL;DR

Cartesian Growth Corp II updated its address and contact info in an 8-K filing on Oct 15, 2024.

AI Summary

On October 15, 2024, Cartesian Growth Corp II filed an 8-K report. The filing indicates that the company's principal executive offices are located at 505 Fifth Avenue, 15th Floor, New York, NY 10017, and its telephone number is (212) 461-6363. This report is a current report filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Why It Matters

This filing provides updated contact and location information for Cartesian Growth Corp II, which is important for investors and stakeholders to know how to reach the company.

Risk Assessment

Risk Level: low — The filing is a routine update of corporate information and does not contain any material non-public information that would typically affect stock price.

Key Players & Entities

• Cartesian Growth Corp II (company) — Registrant
• October 15, 2024 (date) — Date of earliest event reported
• 505 Fifth Avenue, 15th Floor New York, New York 10017 (location) — Principal executive offices
• (212) 461-6363 (phone_number) — Registrant's telephone number

FAQ

Key Financial Figures

• $0.0001 — LC Class A ordinary shares, par value $0.0001 per share RENE The Nasdaq Stock Mar
• $11.50 — ordinary share at an exercise price of $11.50 RENEW The Nasdaq Stock Market LLC
• $100 million — pro forma adjusted EBITDA of more than $100 million. Adjusted EBITDA is neither an IFRS no

Filing Documents

• tm2426010d1_8k.htm (8-K) — 38KB
• 0001104659-24-108951.txt ( ) — 264KB
• reneu-20241015.xsd (EX-101.SCH) — 4KB
• reneu-20241015_def.xml (EX-101.DEF) — 27KB
• reneu-20241015_lab.xml (EX-101.LAB) — 36KB
• reneu-20241015_pre.xml (EX-101.PRE) — 25KB
• tm2426010d1_8k_htm.xml (XML) — 7KB

01. Other Events

Item 8.01. Other Events. On October 15, 2024, Cartesian Growth Corporation II (the "Company") entered into a non-binding letter of intent with a potential target (the "Potential Target") with respect to its initial business combination. The Potential Target in the risk-reduction products sector and would, on a pro forma basis at the closing of such potential business combination, be a market-leading company with operations in multiple countries and is expected to own businesses generating 2025 pro forma adjusted EBITDA of more than $100 million. Adjusted EBITDA is neither an IFRS nor a GAAP measure. The Company is unable to provide a reconciliation of adjusted EBITDA as it is not reconcilable to its most directly comparable IFRS or GAAP measure without unreasonable efforts, because the amounts excluded from the relevant IFRS or GAAP measures used to determine adjusted EBITDA cannot be predicted with reasonable certainty. While the Company is hopeful that it can consummate an initial business combination with the Potential Target, there is no guarantee that the Company will be able to enter into a definitive business combination agreement with the Potential Target or, if such agreement is entered into, that it will be able to consummate a business combination with the Potential Target by the Company's termination date (which may be extended). Any such transaction would be subject to board and stakeholder approval of both the Company and the Potential Target, regulatory approvals and other customary closing conditions. Cautionary Note Regarding Forward-Looking Statements This Current Report on Form 8-K contains "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements may relate to the Company's initial business combination and any other statements relating to future results, strategy and plans of the Company

Forward-looking statements

Forward-looking statements are based on the opinions and estimates of management of the Company as of the date such statements are made, and they are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to the occurrence of any event, change or other circumstances that could give rise to a delay in or the failure to enter into a definitive agreement relating to, or the Company's ability to close an initial business combination, including with the Potential Target, and the financial performance of the Potential Target. Additional information on these and other factors that may cause actual results and the Company's performance to differ materially is included in the Company's periodic reports filed with the SEC, including, but not limited to, the Company's Annual Report on Form 10-K for the year ended December 31, 2023, including those factors described under the heading " Risk Factors " therein, and the Company's subsequent Quarterly Reports on Form 10-Q. Copies of the Company's filings with the SEC are available publicly on the SEC's website at www.sec.gov or may be obtained by contacting the Company. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking These forward-looking statements are made only as of the date hereof, and the Company undertakes no obligations to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Additional In

View Full Filing

View this 8-K filing on SEC EDGAR